• Have a question?
    Open from 8am to 7pm Monday to Friday
    Call customer services
    0345 54 32 600

Polar Capital Healthcare Opports I Inc

Healthcare and Biotechnology
Price: $99.86|Change: 0.54 (-0.54%)

Pricing frequency 

Daily


Dealing cut off time 

13:45


Type 

OEIC


Yield 

–


NAV 

$99.86


Income frequency 

Annually


Ongoing charge 

1.1%


Latest actual NAV date 

13-11-2026


ISIN 

IE00B3K93X10


UCITS 

Yes


Growth of 10k

Asset allocation

Top 10 holdings

Holdings 30/09/2026% of assets
Eli Lilly and Co8.30
Enliven Therapeutics Inc6.99
Teva Pharmaceutical Industries Ltd6.47
argenx SE6.12
Novartis AG Registered Shares5.83
Johnson & Johnson5.14
Torrent Pharmaceuticals Ltd4.87
Abbott Laboratories4.44
Edwards Lifesciences Corp3.42
Uniphar PLC3.27

Performance 31/10/2026

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Fund- 0.54
Category-
More...

Investment objective

The investment objective of the Fund is to preserve capital and achieve long term capital appreciation. The Fund will seek to achieve its investment objective by investing in a globally diversified portfolio of healthcare companies. The Fund will at all times invest at least two thirds of its total assets (excluding cash) in healthcare-related companies worldwide. The Fund will invest at least 51% of its gross assets on a continuous basis directly in Equity Participations. Subject to the investment restrictions described in Appendix II of the Prospectus, investments will be made in transferable securities including, but not limited to, shares, equity warrants and other types of securities such as preferred shares, which may be listed on a Regulated Market or unlisted, and issued by companies, and Global, American and European depository receipts. The Fund may not invest more than 10% of its Net Asset Value in unlisted securities.

Sustainability Label

This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.


Morningstar ratingTM


Morningstar sustainability ratingTM


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.